Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Design Therapeutics, Inc. | 19,000 | reported | 10 Jun 2025 | tx 5+69,300 |
| Entasis Therapeutics Holdings Inc. | 0 | reported | 11 Jul 2022 | tx 4−77,807 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jun 2025 | GRANT_AWARD | Design Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Design Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 25 Mar 2024 | PURCHASE | Design Therapeutics, Inc. | 1,300 | 3.74 USD | |
| 31 May 2023 | GRANT_AWARD | Design Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 07 Jul 2022 | TENDER | Entasis Therapeutics Holdings Inc. | 22,000 | 2.20 USD | |
| 11 Jul 2022 | OTHER | Entasis Therapeutics Holdings Inc. | 27,500 | 2.20 USD | |
| 11 Jul 2022 | OTHER | Entasis Therapeutics Holdings Inc. | 17,307 | 0.00 USD | deriv |
| 11 Jul 2022 | OTHER | Entasis Therapeutics Holdings Inc. | 11,000 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | Design Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |